ロード中...
Antioxidant effect of endothelin-1 receptor antagonist protects the rat kidney against chronic injury induced by hypertension and hyperglycemia
Hypertension and Diabetes mellitus are the two main causes of chronic kidney disease that culminate in the final stage of kidney disease. Since these two risk factors are common and can overlap, new approaches to prevent or treat them are needed. Macitentan (MAC) is a new non-selective antagonist of...
保存先:
| 出版年: | J Bras Nefrol |
|---|---|
| 主要な著者: | , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Sociedade Brasileira de Nefrologia
2019
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6979570/ https://ncbi.nlm.nih.gov/pubmed/31508666 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1590/2175-8239-JBN-2018-0162 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|